(Q57480827)

English

Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties (English)

0 references

author name string

A. Subissi

series ordinal

1

0 references

S. Evangelista

series ordinal

2

0 references

A. Giachetti

series ordinal

3

0 references

publication date

June 1999

0 references

published in

Cardiovascular Drug Reviews

0 references

volume

17

0 references

issue

2

0 references

page(s)

115-133

0 references

cites work

Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Angiotensin-Converting Enzyme Inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Captopril protects against myocardial injury induced by magnesium deficiency

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Captopril and enalaprilat do not scavenge the superoxide anion

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Angiotensin-converting enzyme inhibitors: more different than alike? Focus on cardiac performance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1527-3466.1999.TB00008.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1527-3466.1999.TB00008.X

0 references

(Q57480827)

Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)